Nutex Health Inc.
NUTX
$44.66
-$1.84-3.96%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -41.13M | -37.89M | -41.00M | -45.79M | -28.92M |
Total Depreciation and Amortization | 18.37M | 18.15M | 17.78M | 17.59M | 16.18M |
Total Amortization of Deferred Charges | 2.01M | 2.09M | 2.82M | 2.46M | 3.20M |
Total Other Non-Cash Items | 43.29M | 32.76M | 26.41M | 28.65M | 3.39M |
Change in Net Operating Assets | -1.22M | 1.39M | -2.76M | -1.66M | 13.68M |
Cash from Operations | 21.32M | 16.50M | 3.26M | 1.26M | 7.54M |
Capital Expenditure | -1.08M | -3.34M | -5.85M | -9.50M | -2.44M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | 39.90K | -703.90K | -703.90K | -703.90K | -743.80K |
Divestitures | -361.30K | -711.30K | 0.00 | -1.04M | -1.04M |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -1.40M | -4.76M | -6.56M | -11.24M | -4.23M |
Total Debt Issued | 12.17M | 10.35M | 19.52M | 24.20M | 10.91M |
Total Debt Repaid | -18.08M | -18.80M | -24.36M | -21.56M | -18.17M |
Issuance of Common Stock | 10.96M | 9.50M | 9.82M | 649.60K | 649.60K |
Repurchase of Common Stock | -351.50K | -351.50K | -351.50K | -351.50K | -311.50K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -481.30K | -481.30K | -1.63M | -2.69M | -2.69M |
Other Financing Activities | -4.54M | -4.39M | -5.21M | -5.21M | -6.28M |
Cash from Financing | 162.70K | -3.69M | 471.60K | -2.27M | -13.11M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 20.08M | 8.05M | -2.83M | -12.25M | -9.79M |